This content is machine translated Rituximab, eculizumab, eprodisate New treatment options for glomerular diseases Glomerular diseases are important causes of end-stage renal failure. Pathogenetically, immune-mediated processes are in the foreground. Thanks to advancing knowledge of the pathophysiology and modern genetic engineering methods, there is…
